BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30690954)

  • 1. [Clinical Efficacy of Radiotherapy in
    Park BS; Lee SH
    Korean J Gastroenterol; 2019 Jan; 73(1):19-25. PubMed ID: 30690954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcome for gastric mucosa-associated lymphoid tissue lymphoma according to Helicobacter pylori infection status: a single-center experience.
    Ryu KD; Kim GH; Park SO; Lee KJ; Moon JY; Jeon HK; Baek DH; Lee BE; Song GA
    Gut Liver; 2014 Jul; 8(4):408-14. PubMed ID: 25071906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
    Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
    Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Helicobacter pylori therapy in localized gastric mucosa-associated lymphoid tissue lymphoma: A prospective, nationwide, multicenter study in Japan.
    Sugizaki K; Tari A; Kitadai Y; Oda I; Nakamura S; Yoshino T; Sugiyama T
    Helicobacter; 2018 Apr; 23(2):e12474. PubMed ID: 29504247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
    Sugimoto M; Kajimura M; Shirai N; Furuta T; Kanaoka S; Ikuma M; Sato Y; Hishida A
    Intern Med; 2006; 45(6):405-9. PubMed ID: 16617193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
    Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
    Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: a prospective randomized trial.
    Schmelz R; Miehlke S; Thiede C; Brueckner S; Dawel M; Kuhn M; Ruskoné-Formestraux A; Stolte M; Jentsch C; Hampe J; Morgner A
    J Gastroenterol; 2019 May; 54(5):388-395. PubMed ID: 30327875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of abdominal CT scan as follow-up after complete remission with successful Helicobacter pylori eradication in patients with H. pylori-positive stage I(E1) gastric MALT lymphoma.
    Choi JY; Lee GH; Ahn JY; Kim MY; Lee JH; Choi KS; Kim DH; Choi KD; Song HJ; Jung HY; Kim JH
    Helicobacter; 2011 Feb; 16(1):36-41. PubMed ID: 21241410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori.
    Morgner A; Bayerdörffer E; Neubauer A; Stolte M
    Gastroenterol Clin North Am; 2000 Sep; 29(3):593-607. PubMed ID: 11030075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical Impact Assessment and Utilization Prospects of the t(11:18) Chromosomal Translocation in Gastric MALT Lymphoma in Koreans: A Single Center Retrospective Analysis].
    Jung H; Shin DW; Cheung DY; Lee HH; Kim JI; Park SH; Kim TJ
    Korean J Gastroenterol; 2023 Jan; 81(1):29-35. PubMed ID: 36695064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
    Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy.
    Takigawa H; Yuge R; Masaki S; Otani R; Kadota H; Naito T; Hayashi R; Urabe Y; Oka S; Tanaka S; Chayama K; Kitadai Y
    Gastric Cancer; 2021 Jul; 24(4):937-945. PubMed ID: 33638751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
    Begum S; Sano T; Endo H; Kawamata H; Urakami Y
    J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis.
    Al-Taie O; Al-Taie E; Fischbach W
    Z Gastroenterol; 2014 Dec; 52(12):1389-93. PubMed ID: 25474277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
    Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
    Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gastric Mucosa-associated Lymphoid Tissue Lymphoma Based on Outcome of Domestic Treatment].
    Jung JT
    Korean J Gastroenterol; 2016 Oct; 68(4):175-178. PubMed ID: 27780940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication therapy is effective for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma.
    Asano N; Iijima K; Terai S; Jin X; Ara N; Chiba T; Fushiya J; Koike T; Imatani A; Shimosegawa T
    Tohoku J Exp Med; 2012 Nov; 228(3):223-7. PubMed ID: 23076291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.